Literature DB >> 14671731

Insight in obsessive compulsive disorder and body dysmorphic disorder.

Jane L Eisen1, Katharine A Phillips, Meredith E Coles, Steven A Rasmussen.   

Abstract

Similarities between obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD) have been described in terms of clinical presentation, comorbidity rates, treatment response profiles, and other features. This is the first study to compare insight in OCD and BDD measuring global insight and numerous components of insight. We compared insight in 64 adult outpatients with DSM-IV OCD and 85 adult outpatients with DSM-IV BDD using a reliable and valid measure (the Brown Assessment of Beliefs Scale [BABS]). BDD patients had significantly poorer global insight than OCD patients. BDD patients also had significantly poorer insight on the following components of insight: conviction that the belief is accurate, perception of other's views of the belief, explanation for differing views, willingness to consider that the belief is wrong, and recognition that the belief has a psychiatric/psychological cause. Poorer insight was significantly positively correlated with more severe symptoms of the disorder only in the BDD group.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14671731      PMCID: PMC1613795          DOI: 10.1016/j.comppsych.2003.09.010

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  35 in total

1.  Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach.

Authors:  Katharine A Phillips
Journal:  CNS Spectr       Date:  2002-06       Impact factor: 3.790

2.  Obsessive-compulsive disorder in relation to body dysmorphic disorder.

Authors:  J Tanquary; M Lynch; P Masand
Journal:  Am J Psychiatry       Date:  1992-09       Impact factor: 18.112

3.  Obsessive-compulsive beliefs and treatment outcome.

Authors:  P T Lelliott; H F Noshirvani; M Başoğlu; I M Marks; W O Monteiro
Journal:  Psychol Med       Date:  1988-08       Impact factor: 7.723

4.  Efficacy and safety of fluvoxamine in body dysmorphic disorder.

Authors:  K A Phillips; M M Dwight; S L McElroy
Journal:  J Clin Psychiatry       Date:  1998-04       Impact factor: 4.384

5.  Failure in treating obsessive-compulsives.

Authors:  E B Foa
Journal:  Behav Res Ther       Date:  1979

6.  Dimensions of delusional experience.

Authors:  K S Kendler; W M Glazer; H Morgenstern
Journal:  Am J Psychiatry       Date:  1983-04       Impact factor: 18.112

Review 7.  Disorders with overvalued ideas.

Authors:  P J McKenna
Journal:  Br J Psychiatry       Date:  1984-12       Impact factor: 9.319

8.  A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ralph S Albertini; Steven A Rasmussen
Journal:  Arch Gen Psychiatry       Date:  2002-04

9.  Obsessive-compulsive disorder with psychotic features: a phenomenologic analysis.

Authors:  T R Insel; H S Akiskal
Journal:  Am J Psychiatry       Date:  1986-12       Impact factor: 18.112

10.  A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder.

Authors:  H L Leonard; S E Swedo; M C Lenane; D C Rettew; D L Cheslow; S D Hamburger; J L Rapoport
Journal:  Arch Gen Psychiatry       Date:  1991-10
View more
  46 in total

Review 1.  Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V?

Authors:  Katharine A Phillips; Dan J Stein; Scott L Rauch; Eric Hollander; Brian A Fallon; Arthur Barsky; Naomi Fineberg; David Mataix-Cols; Ygor Arzeno Ferrão; Sanjaya Saxena; Sabine Wilhelm; Megan M Kelly; Lee Anna Clark; Anthony Pinto; O Joseph Bienvenu; Joanne Farrow; James Leckman
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

Review 2.  Body dysmorphic disorder: some key issues for DSM-V.

Authors:  Katharine A Phillips; Sabine Wilhelm; Lorrin M Koran; Elizabeth R Didie; Brian A Fallon; Jamie Feusner; Dan J Stein
Journal:  Depress Anxiety       Date:  2010-06       Impact factor: 6.505

3.  Modular cognitive-behavioral therapy for body dysmorphic disorder: a randomized controlled trial.

Authors:  Sabine Wilhelm; Katharine A Phillips; Elizabeth Didie; Ulrike Buhlmann; Jennifer L Greenberg; Jeanne M Fama; Aparna Keshaviah; Gail Steketee
Journal:  Behav Ther       Date:  2013-12-29

4.  Delusional versus nondelusional body dysmorphic disorder: clinical features and course of illness.

Authors:  K A Phillips; W Menard; M E Pagano; C Fay; R L Stout
Journal:  J Psychiatr Res       Date:  2005-10-17       Impact factor: 4.791

5.  Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder.

Authors:  Katharine A Phillips; William Menard; Christina Fay; Risa Weisberg
Journal:  Psychosomatics       Date:  2005 Jul-Aug       Impact factor: 2.386

6.  Obsessive-compulsive disorder after body dysmorphic disorder: a report of 2 cases (a man and his mother).

Authors:  Fatih Canan; Emel Kocer; Salih Yildirim; Ahmet Ataoglu
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

7.  Psychometric evaluation of the Brown Assessment of Beliefs Scale in body dysmorphic disorder.

Authors:  Katharine A Phillips; Ashley S Hart; William Menard; Jane L Eisen
Journal:  J Nerv Ment Dis       Date:  2013-07       Impact factor: 2.254

8.  Insight and alexithymia in adult outpatients with obsessive-compulsive disorder.

Authors:  Domenico De Berardis; Daniela Campanella; Francesco Gambi; Gianna Sepede; Gabriele Salini; Alessandro Carano; Raffaella La Rovere; Lucia Pelusi; Laura Penna; Alessandra Cicconetti; Carla Cotellessa; Rosa Maria Salerno; Filippo Maria Ferro
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2005-02-21       Impact factor: 5.270

9.  Associations in the longitudinal course of body dysmorphic disorder with major depression, obsessive-compulsive disorder, and social phobia.

Authors:  Katharine A Phillips; Robert L Stout
Journal:  J Psychiatr Res       Date:  2005-11-23       Impact factor: 4.791

Review 10.  Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5.

Authors:  Katharine A Phillips; Ashley S Hart; Helen Blair Simpson; Dan J Stein
Journal:  CNS Spectr       Date:  2013-05-10       Impact factor: 3.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.